Literature DB >> 6721983

Increased forearm vascular resistance after dopamine blockade.

D Mannering, E D Bennett, N Mehta, F Kemp.   

Abstract

The peripheral haemodynamic effects of a 40 mg intravenous injection of domperidone (a dopamine antagonist) have been studied in 10 normal subjects. In four subjects domperidone was infused directly into the brachial artery and the effects on forearm blood flow were measured. When administered systemically, domperidone significantly decreased forearm blood flow by 9% (P less than 0.01) and significantly increased calculated forearm vascular resistance by 11% (P less than 0.01). The drug produced no measurable changes in forearm blood flow at any dose when infused directly into the brachial artery. A further study was carried out into the effects of a systemic injection of domperidone on peripheral sympathetic tone. Reduction of sympathetic tone in the forearm was achieved by passively raising the legs of eight recumbent subjects. Before domperidone administration, passive leg elevation significantly increased forearm blood flow by 39% and decreased forearm vascular resistance by 13%. After drug administration the absolute values of vascular resistance increased and the changes between the supine and elevated position values when compared with those of the corresponding values prior to drug administration were significantly lower. These results suggest that the role of domperidone in increasing peripheral vascular tone is unlikely to be mediated by a direct local effect on peripheral resistance vessels. Any effect the drug may have is suggested to be mediated via a central control mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721983      PMCID: PMC1463392          DOI: 10.1111/j.1365-2125.1984.tb02360.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Reflex changes in vasoconstrictor tone in human skeletal muscle in response to stimulation of receptors in a low-pressure area of the intrathoracic vascular bed.

Authors:  I C RODDIE; J T SHEPHERD; R F WHELAN
Journal:  J Physiol       Date:  1957-12-31       Impact factor: 5.182

2.  The reflex nervous control of human skeletal muscle blood vessels.

Authors:  I C RODDIE; J T SHEPHERD
Journal:  Clin Sci       Date:  1956-08       Impact factor: 6.124

3.  Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms.

Authors:  O S Steinsland; J P Hieble
Journal:  Science       Date:  1978-01-27       Impact factor: 47.728

4.  Effects of prolactin on the responses of rat aortic and arteriolar smooth-muscle preparations to noradrenaline and angiotensin.

Authors:  M S Manku; B A Nassar; D F Horrobin
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

5.  Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.

Authors:  A O Donoso; W Bishop; C P Fawcett; L Krulich; S M McCann
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

6.  Central dopaminergic mechanisms in young patients with essential hypertension.

Authors:  R E Kolloch; K O Stumpe; U Ismer; O Kletzky; V Dequattro
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

7.  The role of domperidone in the regulation of prolactin release in rats.

Authors:  H Kato; T Fujino; S Aramaki; M Koresawa; S Yamashita; T Torigoe
Journal:  Life Sci       Date:  1980-04-21       Impact factor: 5.037

8.  Bromocriptine inhibits norepinephrine release.

Authors:  M G Ziegler; C R Lake; A C Williams; P F Teychenne; I Shoulson; O Steinsland
Journal:  Clin Pharmacol Ther       Date:  1979-02       Impact factor: 6.875

9.  The effects of bromocriptine in patients with congestive heart failure.

Authors:  G S Francis; R Parks; J N Cohn
Journal:  Am Heart J       Date:  1983-07       Impact factor: 4.749

10.  Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.

Authors:  K O Stumpe; R Kolloch; M Higuchi; F Krück; H Vetter
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

View more
  1 in total

1.  The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.

Authors:  A H Altamirano-Espinoza; A González-Hernández; G Manrique-Maldonado; B A Marichal-Cancino; I Ruiz-Salinas; C M Villalón
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.